AzTrials
AzTrials

Autism Spectrum DisorderNSBAANCT05499910

Neuro Strengths-Based Approach to Autism

A study testing NSBAA in people with Autism Spectrum Disorder, run by Baio Enterprises at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Neuro-Strength-Based Approach to Autism (NSBAA) attempts to translate what research has discovered about the autistic brain into terms that autistics, and those involved with autistics, can understand. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
NSBAA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
4 Oct 2022to 30 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 5-20 SLPs / OTR/Ls, regardless of nationality
  • working in a clinical, home or school setting with less than 25 years of experience
  • at least 2 years of experience working with autistic clients

Who cannot join

  • Minors
  • adults unable to consent
  • undocumented individuals
  • prisoners,
  • uncertified therapists
  • therapists from Baio Enterprises.

Trial locations and contacts

1 site in 1 country.

United States1 site

  • Staci L Neustadt

    Littleton, Colorado, 80123

Other trials in United States

About this study

Official title: Training in Neuro Strengths-Based Approach to Autism

The Neuro-Strength-Based Approach to Autism (NSBAA) attempts to translate what research has discovered about the autistic brain into terms that autistics, and those involved with autistics, can understand. It is not intended to be a new approach to intervention but hopefully a unifying approach to understanding autism that all therapists, educators, clinicians, and parents can use when working with autistic individuals. It was developed by an autistic occupational therapist, based on her lifetime obsession of learning everything she could about how typical brains work, and, following her diagnosis, how the autistic brain works. Being on the autism spectrum herself and having worked with, and interacted with, autistic individuals of all ages and abilities in school, clinical, and personal settings, the author attempts to explain the autistic brain from both the scientific as well as autistic perspectives.

Being tested
NSBAA
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NSBAABehavioural

    The Neuro Strengths-Based Approach to Autism is an approach that teaches people how the autistic brain works and the best practices for providing intervention.

Study groups in NCT05499910
Study groupRoleWhat they receive
NSBAAExperimentalThe Neuro Strengths-Base Approach to Autism is an approach developed from various research on how the autistic brain works, the approaches that work best to motivate autistic individuals, and how others can understand as well as support behaviors that may occur with autistic individuals.
Receives: Behavioral: NSBAA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurable change in the participant's satisfaction with their ability to write neuro-strength-based goals

    Participants will show a significant increase (50% or higher) in their ratings on the NSBSA Satisfaction With Writing and Implementing Goals For Autistic Clients given to them pre-training, 3 months post-training, and 6 months post-training. They will rate their satisfaction with 28 elements included in the NSBSA Training Modules using a rating scale of 1-5, with 1 being very dissatisfied and 5 being very satisfied. The highest possible score is 140 and the lowest is 28.

    Measured: After 16 hours of training

  2. Measurable change in participants' knowledge of the clinical reasoning for the goals they write

    Participants will show a significant increase (50% or higher) in the number of goal components they are able to include in their goal, with a maximum of 8, and the number of questions that challenge their reasoning for what they include, with a maximum of 23, in the goals they submit using the Pre- and Post-Training Goal Writing Forms. The highest possible score is 31 if they complete all components and answer all questions. The lowest possible score is 0.

    Measured: After 16 hours of training

Secondary outcomes (1)

  1. Measurable change in the completeness of the goals:

    Participants will show a significant increase (50% or higher) in the score they receive on the Post-Training Goal Writing Form compared to the Pre-Training Goal Writing Form, using the Pre-and Post-Training Scoring for Goal Writing Form, with the highest possible score being +32 and the lowest score being -16 with an average score of 0.

    Measured: After 16 hours of training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2022
  2. Study start4 Oct 2022
  3. Primary completion13 Dec 2022
  4. Study completion30 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05499910
Sponsor's protocol ID
STUDY00015835
Acronym
NSBAA
Status last verified
Sep 2024
First submitted
18 Jul 2022
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wolff, Michael. (2018). The Complexity of Autism Spectrum Disorders

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 2013. 646

  • Wozniak RH, Leezenbaum NB, Northrup JB, West KL, Iverson JM. The development of autism spectrum disorders: variability and causal complexity. Wiley Interdiscip Rev Cogn Sci. 2017 Jan;8(1-2):10.1002/wcs.1426. doi: 10.1002/wcs.1426. Epub 2016 Dec 1.

    PubMed 27906524

  • Ha S, Sohn IJ, Kim N, Sim HJ, Cheon KA. Characteristics of Brains in Autism Spectrum Disorder: Structure, Function and Connectivity across the Lifespan. Exp Neurobiol. 2015 Dec;24(4):273-84. doi: 10.5607/en.2015.24.4.273. Epub 2015 Dec 16.

    PubMed 26713076

  • Riosa, Priscilla & Chan, Victoria & Maughan, Andrea & Stables, Victoria & Albaum, Carly & Weiss, Jonathan. (2017). Remediating Deficits or Increasing Strengths in Autism Spectrum Disorder Research: a Content Analysis. Advances in Neurodevelopmental Disorders. 1. 10.1007/s41252-017-0027-3.

  • Urbanowicz A, Nicolaidis C, den Houting J, Shore SM, Gaudion K, Girdler S, Savarese RJ. An Expert Discussion on Strengths-Based Approaches in Autism. Autism Adulthood. 2019 Jun 1;1(2):82-89. doi: 10.1089/aut.2019.29002.aju. Epub 2019 Apr 13. No abstract available.

    PubMed 36601531

  • Donaldson A, Krejcha K, McMillin A. A Strengths-Based Approach to Autism: Neurodiversity and Partnering With the Autism Community. Perspectives of the ASHA Special Interest Groups (2017) 2(1) 56-68

  • Patten Koenig K. A strength-based frame of reference for autistic individuals. Frames of reference for pediatric occupational therapy (4th edition) (2019)

  • Patten Koenig K. Authentic Strength-Based Practice: Can Neurotypical Professionals Make a Paradigm Shift? Autism Spectrum News (2020) (Winter)

  • Leadbitter K, Buckle KL, Ellis C, Dekker M. Autistic Self-Advocacy and the Neurodiversity Movement: Implications for Autism Early Intervention Research and Practice. Front Psychol. 2021 Apr 12;12:635690. doi: 10.3389/fpsyg.2021.635690. eCollection 2021.

    PubMed 33912110

Questions about this trial

What is this clinical trial studying?

A study testing NSBAA in people with Autism Spectrum Disorder, run by Baio Enterprises at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurable change in the participant's satisfaction with their ability to write neuro-strength-based goals (time frame: After 16 hours of training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05499910, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in